UTEC - The University of Tokyo Edge Capital Partners
VC Fund
Tokyo, Japan
UTEC - The University of Tokyo Edge Capital Partners is a VC fund in Tokyo focused on Health Care and Biotechnology. UTEC - The University of Tokyo Edge Capital Partners, is a Japan-based seed/early stage deep-tech venture capital firm associated with academic institutes such as The University of Tokyo. UTEC has over $1 billion in Assets Under Management, and has invested in 150+ companies in Japan, USA, Singapore, India and Europe with a track record of 20 IPOs and 22 successful M&A (as of Nov 2025). UTEC predominantly invests in three deep-tech sectors: a) Healthcare & Life Sciences, b) IT/AI, and c) Physical Sciences & Engineering.
- Total investments:
- 216
- Last investment:
- Lead investor:
- 38%
- Fund size:
- $326M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries UTEC - The University of Tokyo Edge Capital Partners invests in
Stages UTEC - The University of Tokyo Edge Capital Partners invests in
Countries UTEC - The University of Tokyo Edge Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $624k–$11M
- Series A
- $2.3M–$18M
- Venture - Series Unknown
- $2.2M–$13M
Investment Focus
Industry
- Health Care 23 (11%)
- Biotechnology 21 (10%)
- Medical 19 (9%)
- Manufacturing 19 (9%)
- Artificial Intelligence 18 (8%)
Stage
- Series A 43 (20%)
- Seed 41 (19%)
- Venture - Series Unknown 32 (15%)
- Series B 31 (14%)
- Series C 9 (4%)
Country
- Japan 79 (37%)
- United States 15 (7%)
- India 5 (2%)
- Singapore 5 (2%)
- United Kingdom 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Atsushi Usami
Partner & Board Director
|
Partner & Board Director | Total investments: 15 | Find email | |
Hiroaki Kobayashi
Principal
|
Principal | Total investments: 5 | Find email | |
Keisuke Ide
Partner
|
Partner | Total investments: 1 | Find email | |
Kiran Mysore
Principal
|
Principal | Total investments: 13 | Find email | |
Maiko Katadae
Partner
|
Partner | Total investments: 1 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy. | $11.3M / Venture - Series Unknown / Sep 24, 2026 | ||
| RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer . | $44M / Series A / Sep 15, 2026 | ||
| Corporate Site：https://www.xmile.co.jp/ Service Site：https://x-work.jp/ | $20.1M / Series C / Aug 04, 2026 | ||
| Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology. | $3.4M / Seed / Jul 29, 2026 | ||
| Piece is a digital real estate investment platform offering the easiest and most transparent way to invest in income-producing real estate in Europe. Our mission is to make real estate ownership inclusive and more accessible. | $1.9M / Seed / Jul 13, 2026 | ||
| KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices. | Secondary Market / Jul 07, 2026 | ||
| KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices. | $10.1M / Series B / Jul 07, 2026 | ||
| ALGO ARTIS is a software company that offers optimization in plant operations, tanking, ship allocation plan, and logistics. | $9.6M / Series B / Jun 09, 2026 | ||
| Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. | $350M / Series C / Jun 03, 2026 | ||
| Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions. | $14.4M / Series B / Jun 01, 2026 | ||
| See all 216 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does UTEC - The University of Tokyo Edge Capital Partners invest in?
UTEC - The University of Tokyo Edge Capital Partners invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 216 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does UTEC - The University of Tokyo Edge Capital Partners invest in?
UTEC - The University of Tokyo Edge Capital Partners typically joins rounds of $624k–$11M at Seed, $2.3M–$18M at Series A and $2.2M–$13M at Venture - Series Unknown. These are whole funding-round sizes, not UTEC - The University of Tokyo Edge Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds UTEC - The University of Tokyo Edge Capital Partners took part in.
How do I contact UTEC - The University of Tokyo Edge Capital Partners?
Public channels for UTEC - The University of Tokyo Edge Capital Partners include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at UTEC - The University of Tokyo Edge Capital Partners?
The team at UTEC - The University of Tokyo Edge Capital Partners includes Atsushi Usami (Partner & Board Director), Hiroaki Kobayashi (Principal) and Keisuke Ide (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
